HIGHLIGHTS
- who: Xiangjuan Guo and colleagues from the University, China have published the paper: A case report of hepatitis B virus reactivation 19 months after cessation of chemotherapy with rituximab, in the Journal: (JOURNAL) of August/19,/2021
- what: The authors report a case of HBV reactivation 19 months after cessation of chemotherapy with rituximab for diffuse large B-cell lymphoma in a patient with resolved hepatitis B infection (HBsAg negative, HBcAb positive and HBV DNA negative).
SUMMARY
HBV reactivation is a well-known complication of HBV infected patients undergoing chemotherapy or . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.